	US 11,938,139 B2
	Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
Jianmin Wang, Blacksburg, VA (US); and Geping Cui, Beijing (CN)
Assigned to LA PharmaTech Inc., Blacksburg, VA (US)
Filed by LA PharmaTech Inc., Blacksburg, VA (US)
Filed on May 27, 2020, as Appl. No. 16/884,459.
Application 16/884,459 is a continuation in part of application No. 16/382,885, filed on Apr. 12, 2019, granted, now 10,966,989.
Prior Publication US 2020/0323876 A1, Oct. 15, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/5517 (2006.01); A61K 9/00 (2006.01)

CPC A61K 31/5517 (2013.01) [A61K 9/0053 (2013.01)]

8 Claims

1. A pharmaceutical composition, comprising:

azelastine or a pharmaceutically acceptable salt of azelastine, wherein the azelastine or the pharmaceutically acceptable salt of azelastine is present in the pharmaceutical composition in an amount of about 2 mg;

alprazolam, wherein the alprazolam is present in the pharmaceutical composition, and is present in an amount of about 0.4 mg;

and one or more pharmaceutically acceptable excipients.